In accordance with these studies, our previous studies have reported that Dex alleviates the inflammatory response induced by hemorrhagic shock/resuscitation-endotoxemia, while the administration of an α2AR inhibitor reverses the anti-inflammatory effects of Dex [13], suggesting α2AR-mediated effect is an important mechanism. The gene discussed is ADORA2A; the disease is serum lipopolysaccharide activity.